Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 72789-153

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 72789-153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789153 Label (72789153)

72789153 Label (72789153)
This is a description of a pharmaceutical product with the NDC code 72789-153-30. The product is manufactured by HOP Pharmaceuticals and contains three different types of atorvastatin calcium USP: 10 MG, 10MG, and 10 MG. It comes in a bottle with 30 tablets and the lot number is E21621. The tablets are to be taken 3 times a day and the batch is valid until July 2022. The description also includes a warning to consult a doctor about side effects.*
FDA Label Image

Figure-01 (Atorvastatin Figure 01)

FDA Label Image

Figure-02 (Atorvastatin Figure 02)

Figure-02 (Atorvastatin Figure 02)
This is a statistical analysis output from a study over a period of four years. The graph depicts the cumulative hazard percentage over time and a hazard ratio of 0.63 with a confidence interval of (0.48-0.83) and a p-value of 0.001, indicating a statistically significant result. No information is available about the primary endpoint or the population under study.*
FDA Label Image

Figure-03 (Atorvastatin Figure 03)

Figure-03 (Atorvastatin Figure 03)
The text presents a table of percentages of subjects experiencing an event, with two dosages of Atorvastatin (10 mg and 80 mg) being compared. The results show that the higher dosage had a significant reduction in the occurrence of major cardiovascular events compared to the lower dosage. The study also reports a hazard ratio of 0.78 with a statistically significant p-value of 0.0002. The duration of the study is not specified.*
FDA Label Image

Structure (Atorvastatin Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.